ArticleCureus2026
Usher Syndrome Type 2D Associated With a Novel Homozygous Whrn c.74dup Variant: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Variants of the WHRN/DFNB31 gene cause Usher syndrome type 2D (USH2D), a rare subtype of Usher syndrome. Usher syndrome is an autosomal recessive disorder characterized by sensorineural hearing loss and progressive retinal degeneration due to retinitis pigmentosa. We report the case of a 63-year-old woman with clinical and genetic findings consistent with USH2D. Ophthalmic evaluation demonstrated reduced visual acuity, bilateral optic disc pallor, mid-peripheral bony spicules, vascular attenuation, and macular abnormalities. Full-field electroretinography showed non-recordable photopic and scotopic responses bilaterally, consistent with extinguished rod and cone responses. Macular optical coherence tomography demonstrated a central subfield thickness of 220 µm (oculus dexter or right eye (OD)) and 235 µm (oculus sinister or left eye (OS)), a cube volume of 7.8 mm³ OD and 6.5 mm³ OS, and an average cube thickness of 215 µm OD and 180 µm OS, supporting structural macular involvement. Electrooculography demonstrated an abnormal Arden ratio of 1.58 in both eyes, consistent with retinal pigment epithelium dysfunction. Based on these ocular findings, the patient was diagnosed with retinitis pigmentosa. Genetic testing with next-generation sequencing identified a homozygous pathogenic WHRN c.74dup (p.Gly26Argfs*153) variant. To our knowledge, this specific frameshift variant has not been previously reported in the literature in affected individuals with WHRN-related disease. This case highlights the importance of genetic testing and multimodal ophthalmic evaluation in patients with inherited retinal dystrophies and contributes to the limited literature describing Usher syndrome due to WHRN mutations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.